tlooto
Sign up
Medicine

The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation.

Christo Albor, Oluwaseun Anyiam, Luke D. Boyle, Janine Makaronidis, Rachael J L Tan, Sahar Iftikhar, A. Burzic, Fannie Lajeunesse Trempe, Moira Stanley, A. Bhatti, Jadine Scragg, L. Badawy, Komal Moqeem, Iskandar Idris, Robert C. Andrews, P. Sen Gupta, David Hughes, Katherine McCullough, Tricia Tan, Barbara McGowan

2026.4.2Current Obesity Reports

DOI: 10.1007/s13679-026-00707-6

Abstract

Abstract is not available.

Citation format

ALBOR, Christo, et al. The role of GLP1 receptor agonists and multi-agonist incretin therapies for specific obesity-related health conditions: Evidence and rationale for prioritisation. Current Obesity Reports, 2026, 15 1(1).